Tag: Clinical trials
Expecto Health Science secures growth capital to accelerate Asia-Pacific expansion
The investment strengthens Expecto’s ability to scale its operations across Asia-Pacific and enhances cross-regional integration between early-phase development in Australia
Syngene collaborates with Johns Hopkins University to advance early-stage drug discovery
The collaboration is anchored in Syngene’s SynVent platform and Connector model to accelerate promising academic research
Dr V.K Paul, Member NITI Aayog graces IMTECH’s 42nd Foundation Day
He outlined a roadmap for IMTECH scientists, urging them to focus on priority pathogens with pandemic potential, develop countermeasures up to Phase II clinical trials
Roche partners 10 govt hospitals to strengthen clinical trial capabilities in...
Initiative aligns with CDSCO priorities to boost participation of government sites in Phase 3 and 4 Trials
“AI is reshaping clinical trial design and execution, especially in India”
Dr Saurabh Arora, Managing Director, Auriga Research shares insights on the growing influence of AI in the clinical trials ecosystem; company’s latest partnerships, current activities and future outlook
Sun Pharma discontinues studies of its drug for psoriasis & atopic...
The Phase 2 atopic dermatitis study of SCD-044 included 250 people and compared three different dosages of SCD-044 with placebo
Post CDSCO approval, Lilly launches Mounjaro, a first of its kind...
The drug delivers superior A1C reductions versus all comparators in phase 3 SURPASS clinical trials
SunAct Cancer Institute ties up with Singapore’s CytoMed for phase 2...
This is a cutting-edge cancer treatment that uses special immune cells called Gamma Delta T-Cells
Alkem signs licensing deal with Sonnet BioTherapeutics to launch its drug...
Sonnet’s drug candidate “SON-080” has shown encouraging data in phase 1b clinical trial
ICMR signs MOAs with industry & academic partners to advance first-in-human...
The partnership marks a pivotal step towards establishing India’s self-sufficiency in clinical development and advancing indigenous pharmaceutical agents